Oncology

Top news of the week from Specialty Pharmacy Times.

Study finds association between warfarin use and cancer incidence to determine whether warfarin has anticancer potential.

Heplisav-B is the only 2-dose hepatitis B vaccine recombinant approved in the United States.

Brentuximab vedotin (Adcetris) improves survival among patients with anaplastic large cell lymphoma or CD30-expressing mycosis fungoides.

Brentuximab vedotin (Adcetris) improves survival among patients with anaplastic large cell lymphoma or CD30-expressing mycosis fungoides.

Ribociclib (Kisqali) combination therapy may improve survival among premenopausal breast cancer patients.

A comprehensive knowledge of the risk of breast cancer can lead to better screening.

Patients without cirrhosis who achieved a sustained virological response had the lowest risk of hepatocellular carcinoma linked to hepatitis C virus.

Patients with hepatitis C who achieved sustained virologic response with a direct-acting antiviral maintained health improvements that enhanced their long-term quality of life.

Alectinib (Alecensa) found to reduce the risk of disease progression in patients with metastatic non-small cell lung cancer.

An aspirin a day may reduce their risk of hepatocellular carcinoma in patients with hepatitis B virus.

Trastuzumab monotherapy was not linked to surgical complications among patients with breast cancer undergoing reconstruction after a mastectomy.

Glucose is crucial for the growth of brain cancer cells.

Norepinephrine may increase blood vessel growth in prostate cancer tumors.

Many new antiviral drugs that treat hepatitis C have similar efficacy, but come with different advantages and disadvantages.

A byproduct of cholesterol metabolism may fuel the spread of solid tumors.

Exposure to many chemicals, including gasoline, can heighten the risk of developing breast cancer.

New discovery about EGFR signaling may prevent cancer cells from spreading.

PQIs, developed by a team of NCODA clinical pharmacists, provide medication management tools that focus on specific issues associated with managing oral cancer drug therapies.

Varubi indicated for use in combination with other antiemetic agents to treat delayed chemotherapy-induced nausea and vomiting in adults.

Hepatitis B virus is known to increase the risk of cirrhosis and hepatocellular carcinoma.

The mechanisms of BRCA mutations are still largely unknown.

Mammography plays an important role in breast cancer detection.

Early detection is crucial for breast cancer survival.

Patients undergoing chemotherapy can use Emend with other antiemetic medicines to prevent chemotherapy-related nausea and vomiting.

Patients undergoing chemotherapy can use Emend with other antiemetic medicines to prevent CINV.

Top news of the day from across the healthcare landscape.